3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
11
Carcinoma, Non-Small-Cell Lung
9
Recurrence
7
Colorectal Neoplasms
6
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, T-Cell, Peripheral
4
Colonic Neoplasms
4
Rectal Neoplasms
3
Lymphoma, T-Cell
3
Lung Neoplasms
3
Sezary Syndrome
2
Mycosis Fungoides
2
Meningeal Carcinomatosis
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, B-Cell
2
Lymphoma
2
Infertility
2
Hyperandrogenism
2
Head and Neck Neoplasms
2
Breast Neoplasms
2
Atypical Squamous Cells of the Cervix
2
Anovulation
2
Adenoma
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Diseases
1
Thrombocytopenia
1
Interventions
Etanercept
7
tofacitinib
6
Adalimumab
4
Methotrexate
3
secukinumab
2
sotrastaurin
1
sodium luminolate
1
purine
1
ixekizumab
1
fumaric acid
1
calcipotriene
1
baricitinib
1
apremilast
1
Vitamin D
1
Vaccines
1
Sulfasalazine
1
Saline Solution
1
Mesalamine
1
Mercaptopurine
1
Infliximab
1
Herpes Zoster Vaccine
1
Folic Acid
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Eating
1
Docosahexaenoic Acids
1
Cholecalciferol
1
Biopsy
1
Anti-Infective Agents, Local
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Psoriasis
×
Folic Acid
×
Clear all
NCT00932113
2017-08-31
MOA
Tufts Medical Center
Phase 4
Completed
33 enrolled
11 charts